Arla Foods Ingredients introduced a patented method, milk fractionation, that separates milk into its different protein components.
Arla Foods Ingredients introduced a patented method, milk fractionation, that separates milk into its different protein components that enable scientists, nutritionists, and health professionals to develop specialized nutrient-specific foods for infant formulas, sports products, and medical nutrition.
“The method has been several years in development, and I’m delighted to see what was once a vision become a commercial reality with the power to completely revolutionize targeted nutrition for vulnerable groups,” said Henrik Andersen, CEO of Arla Foods Ingredients, in a press release. “As science-based innovators we are driven to invent and reinvent our processes to ensure we have the best possible products available and continue to lead the way in whey.”
The separation of milk’s different proteins from whey previously relied on cheese-making, as whey is a byproduct of this process—this new technology bypasses this process.
“Traditional cheese-making demands significant quantities of organic milk to produce the volumes of whey we require to meet demand, and now that we’re not reliant on this we can significantly increase production and, at the same time, offer parents and guardians greater clarity of the provenance of the organic infant milk formula because just a few Arla farms supply the milk to our factory in Videbaek,” Andersen said.
Arla Foods is currently using the new technology to manufacture the organic Baby&Me brand for Arla Foods and expects to launch its first organic private-label infant-formula solutions based on the technology in 2022.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.